Barry D. Quart, Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 10,000 shares at $11.75 ($118K) on 2014-06-25, disclosed to the SEC on 2014-06-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |